Trial Profile
Double-Blind, Single-Center Interventional Trial To Evaluate The Effect Of Intravenous Iron Versus Placebo On Cerebral Dopamine Receptor Density In Non Anaemic Premenopausal Women With Low Ferritin Levels And Fatigue
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 12 Oct 2017 Planned initiation date changed from 16 Oct 2017 to 23 Oct 2017.
- 12 Oct 2017 New trial record